Aemetis, Inc. (NASDAQ:AMTX) Receives Consensus Rating of “Moderate Buy” from Analysts

Aemetis, Inc. (NASDAQ:AMTX) has been given a consensus recommendation of “Moderate Buy” by the five research firms that are currently covering the stock, MarketBeat.com reports. One analyst has rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 12 month price objective among analysts that have updated their coverage on the stock in the last year is $12.95.

Several analysts have issued reports on the stock. Ascendiant Capital Markets decreased their price target on shares of Aemetis from $20.00 to $19.00 and set a “buy” rating on the stock in a research report on Tuesday, September 3rd. StockNews.com raised Aemetis to a “sell” rating in a research note on Wednesday, July 31st. UBS Group cut their price target on shares of Aemetis from $8.25 to $7.75 and set a “buy” rating for the company in a report on Monday, August 19th. Truist Financial reaffirmed a “hold” rating and set a $3.50 price objective (down previously from $4.00) on shares of Aemetis in a report on Wednesday, July 31st. Finally, HC Wainwright reissued a “buy” rating and issued a $28.00 target price on shares of Aemetis in a report on Friday, August 2nd.

Aemetis Price Performance

NASDAQ AMTX opened at $2.98 on Wednesday. The firm has a market cap of $132.31 million, a P/E ratio of -2.55 and a beta of 1.24. The stock’s 50-day moving average is $2.56 and its two-hundred day moving average is $3.12. Aemetis has a fifty-two week low of $2.10 and a fifty-two week high of $7.03.

Aemetis (NASDAQ:AMTX) last announced its earnings results on Thursday, August 1st. The specialty chemicals company reported ($0.66) EPS for the quarter, missing the consensus estimate of ($0.41) by ($0.25). The company had revenue of $66.56 million for the quarter, compared to analysts’ expectations of $75.37 million. During the same quarter in the previous year, the business earned ($0.68) EPS. On average, equities analysts expect that Aemetis will post -2.07 EPS for the current year.

Institutional Trading of Aemetis

Several hedge funds have recently modified their holdings of AMTX. Bank of New York Mellon Corp acquired a new position in Aemetis during the 2nd quarter worth $306,000. Susquehanna Fundamental Investments LLC raised its position in shares of Aemetis by 287.4% during the second quarter. Susquehanna Fundamental Investments LLC now owns 126,078 shares of the specialty chemicals company’s stock worth $379,000 after acquiring an additional 93,536 shares during the last quarter. Rhumbline Advisers raised its position in shares of Aemetis by 2,837.1% during the second quarter. Rhumbline Advisers now owns 52,309 shares of the specialty chemicals company’s stock worth $157,000 after acquiring an additional 50,528 shares during the last quarter. Hutchinson Capital Management CA acquired a new position in shares of Aemetis during the second quarter valued at $70,000. Finally, State Board of Administration of Florida Retirement System bought a new position in Aemetis in the first quarter valued at about $84,000. 27.02% of the stock is owned by institutional investors.

About Aemetis

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.